Intellia Therapeutics Company
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Investors
Connections from
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2014
Last Funding Date:
2021-06-30
Total Funding:
775000000
Employee Number:
251-500
Estimated Revenue:
$10M to $50M
Investors Number:
9
Industry:
Gene therapy